For persistent depression, FDA approves a novel treatment based on ketamine
Tuesday, March 5, 2019 - 23:20
in Health & Medicine
The Food and Drug Administration approved a novel antidepressant — the first in decades to work in a completely new way in the brain — for people with depression that does not respond to other treatments. The drug, a nasal spray called esketamine, has been eagerly anticipated by psychiatrists and...